Abstract
Tumor‐specific
frameshift
mutations
encoding
peptides
(FSPs)
are
highly
immunogenic
neoantigens
for
personalized
cancer
immunotherapy,
while
their
clinical
efficacy
is
limited
by
immunosuppressive
tumor
microenvironment
(TME)
and
self‐tolerance.
Here,
a
thermosensitive
hydrogel
(FSP‐RZ‐BPH)
delivering
dual
adjuvants
R848
(TLR7/8
agonist)
+
Zn
2+
(cGAS‐STING
designed
to
promote
the
of
FSPs
on
murine
forestomach
(MFC).
After
peritumoral
injection,
FSP‐RZ‐BPH
behaves
as
pH‐responsive
sustained
drug
release
at
sites
near
effectively
transform
TME
into
an
inflammatory
type.
orchestrates
innate
adaptive
immunity
activate
dendritic
cells
in
tumor‐draining
lymph
nodes
increase
number
FSPs‐reactive
effector
memory
T
(
EM
)
2.9
folds.
More
importantly,
these
also
exhibit
responses
nonvaccinated
MFC.
This
epitope
spreading
effect
contributes
reduce
self‐tolerance
maintain
long‐lasting
anti‐tumor
immunity.
In
MFC
suppressive
model,
achieves
84.8%
inhibition
rate
prolongs
survival
tumor‐bearing
mice
with
57.1%
complete
response
rate.
As
preventive
vaccine,
can
significantly
delay
growth.
Overall,
work
identifies
first
time
demonstrates
bi‐adjuvant
effective
strategy
boost
bystander
neoantigens.
Molecular Medicine Reports,
Год журнала:
2024,
Номер
29(4)
Опубликована: Фев. 8, 2024
The
present
study
was
designed
to
explore
the
role
of
M2
macrophage‑derived
exosomes
(M2‑exos)
on
KCa3.1
channel
in
a
cellular
atrial
fibrillation
(AF)
model
using
rapidly
paced
HL‑1
myocytes.
macrophages
and
M2‑exos
were
isolated
identified.
MicroRNA
(miR)‑146a‑5p
levels
quantified
reverse
transcription‑quantitative
PCR
(RT‑qPCR).
myocytes
randomly
divided
into
six
groups:
Control
group,
pacing
+
coculture
group
(pacing
cells
cocultured
with
M2‑exos),
mimic‑miR‑146a‑5p
NC‑miR‑146a‑5p
pyrrolidine
dithiocarbamate
(PDTC;
special
blocker
NF‑κB
signaling
pathway)
group.
Transmission
electron
microscopy,
nanoparticle
tracking
analysis,
western
blotting,
RT‑qPCR
immunohistochemistry
performed
study.
A
whole‑cell
clamp
also
applied
record
current
density
action
potential
duration
(APD)
each
results
revealed
that
miR‑146a‑5p
highly
expressed
both
M2‑exos.
Pacing
led
shorter
APD,
an
increased
higher
protein
KCa3.1,
phosphorylated
(p‑)NF‑κB
p65,
p‑STAT3
IL‑1β
compared
control
M2‑exos,
miR‑146a‑5p‑mimic
PDTC
reduced
expression
p‑NF‑κB
resulting
longer
APD
cells.
In
conclusion,
their
cargo,
which
comprised
miR‑146a‑5p,
decreased
secretion
via
NF‑κB/STAT3
pathway,
limiting
caused
by
rapid
pacing.
EMBO Molecular Medicine,
Год журнала:
2023,
Номер
15(12)
Опубликована: Ноя. 27, 2023
Tumor
endothelial
cells
(TECs)
actively
repress
inflammatory
responses
and
maintain
an
immune-excluded
tumor
phenotype.
However,
the
molecular
mechanisms
that
sustain
TEC-mediated
immunosuppression
remain
largely
elusive.
Here,
we
show
autophagy
ablation
in
TECs
boosts
antitumor
immunity
by
supporting
infiltration
effector
function
of
T-cells,
thereby
restricting
melanoma
growth.
In
melanoma-bearing
mice,
loss
TEC
leads
to
transcriptional
expression
immunostimulatory/inflammatory
phenotype
driven
heightened
NF-kB
STING
signaling.
line,
single-cell
transcriptomic
datasets
from
patients
disclose
enriched
InflammatoryHigh
/AutophagyLow
correlation
with
clinical
immunotherapy,
responders
exhibit
increased
presence
inflamed
vessels
interfacing
infiltrating
CD8+
T-cells.
Mechanistically,
STING-dependent
is
not
critical
for
immunomodulatory
effects
ablation,
since
NF-kB-driven
inflammation
remains
functional
STING/ATG5
double
knockout
TECs.
Hence,
our
study
identifies
as
a
principal
vascular
anti-inflammatory
mechanism
dampening
immunity.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Фев. 15, 2024
The
incidence
of
hepatocellular
carcinoma
(HCC)
ranks
first
among
primary
liver
cancers,
and
its
mortality
rate
exhibits
a
consistent
annual
increase.
treatment
HCC
has
witnessed
significant
surge
in
recent
years,
with
the
emergence
targeted
immune
therapy
as
an
adjunct
to
early
surgical
resection.
Adoptive
cell
(ACT)
using
tumor-infiltrating
lymphocytes
(TIL)
shown
promising
results
other
types
solid
tumors.
This
article
aims
provide
comprehensive
overview
intricate
interactions
between
different
TILs
their
impact
on
HCC,
elucidate
strategies
for
targeting
neoantigens
through
TILs,
address
challenges
encountered
TIL
therapies
along
potential
solutions.
Furthermore,
this
specifically
examines
oncogenic
signaling
pathways
activation
within
tumor
microenvironment
infiltration
dynamics
TILs.
Additionally,
concise
is
provided
regarding
preparation
techniques
update
clinical
trials
investigating
TIL-based
immunotherapy
Abstract
Tumor‐specific
frameshift
mutations
encoding
peptides
(FSPs)
are
highly
immunogenic
neoantigens
for
personalized
cancer
immunotherapy,
while
their
clinical
efficacy
is
limited
by
immunosuppressive
tumor
microenvironment
(TME)
and
self‐tolerance.
Here,
a
thermosensitive
hydrogel
(FSP‐RZ‐BPH)
delivering
dual
adjuvants
R848
(TLR7/8
agonist)
+
Zn
2+
(cGAS‐STING
designed
to
promote
the
of
FSPs
on
murine
forestomach
(MFC).
After
peritumoral
injection,
FSP‐RZ‐BPH
behaves
as
pH‐responsive
sustained
drug
release
at
sites
near
effectively
transform
TME
into
an
inflammatory
type.
orchestrates
innate
adaptive
immunity
activate
dendritic
cells
in
tumor‐draining
lymph
nodes
increase
number
FSPs‐reactive
effector
memory
T
(
EM
)
2.9
folds.
More
importantly,
these
also
exhibit
responses
nonvaccinated
MFC.
This
epitope
spreading
effect
contributes
reduce
self‐tolerance
maintain
long‐lasting
anti‐tumor
immunity.
In
MFC
suppressive
model,
achieves
84.8%
inhibition
rate
prolongs
survival
tumor‐bearing
mice
with
57.1%
complete
response
rate.
As
preventive
vaccine,
can
significantly
delay
growth.
Overall,
work
identifies
first
time
demonstrates
bi‐adjuvant
effective
strategy
boost
bystander
neoantigens.